Guanosine is a guanine-based purine that modulates glutamate uptake and exerts neurotrophic and neuroprotective effects. In a previous study, our group demonstrated that this endogenous nucleoside displays antidepressant-like properties in a predictive animal model. Based on the role of oxidative stress in modulating depressive disorders as well as on the association between the neuroprotective and antioxidant properties of guanosine, here we investigated if its antidepressant-like effect is accompanied by a modulation of hippocampal oxidant/antioxidant parameters. Adult Swiss mice were submitted to an acute restraint stress protocol, which is known to cause behavioral changes that are associated with neuronal oxidative damage. Animals submitted to ARS exhibited an increased immobility time in the forced swimming test (FST) and the administration of guanosine (5 mg/kg, p.o.) or fluoxetine (10 mg/kg, p.o., positive control) before the exposure to stressor prevented this alteration. Moreover, the significantly increased levels of hippocampal malondialdehyde (MDA; an indicator of lipid peroxidation), induced by ARS were not observed in stressed mice treated with guanosine. Although no changes were found in the hippocampal levels of reduced glutathione (GSH), the group submitted to ARS procedure presented enhanced glutathione peroxidase (GPx), glutathione reductase (GR), superoxide dismutase (SOD) activities and reduced catalase (CAT) activity in the hippocampus. Guanosine was able to prevent the alterations in GPx, GR, CAT activities, and in SOD/CAT activity ratio, but potentiated the increase in SOD activity elicited by ARS. Altogether, the present findings indicate that the observed antidepressant-like effects of guanosine might be related, at least in part, to its capability of modulating antioxidant defenses and mitigating hippocampal oxidative damage induced by ARS.
Introduction
Stressful life experiences are recognized as a major risk factor for cardiovascular, metabolic and neuropsychiatric diseases (Musazzi et al., 2010) . Among the stress related psychiatry disorders, a great amount of evidence indicates the involvement of stressful events with major depression, a debilitating disease with high prevalence worldwide (Krishnan and Nestler, 2008; Paykel, 2003) . This observation can be explained by the occurrence of morphological remodeling as well as molecular, neurochemical and electrophysiological changes associated with stress that can lead to the cognitive deficits observed in depressive patients (Herman and Cullinan, 1997) . In this scenario, the hippocampus, an encephalic area that plays a key role in learning and memory, is also deeply involved in the pathophysiology of depression and in the action of antidepressant drugs (Kim et al., 2012; McEwen, 1999 McEwen, , 2000 . Due to its high levels of glucocorticoid receptors (the main intracellular mediators of stress response), this brain structure is particularly sensitive to stressful events (McEwen, 2005) . Moreover, the hippocampus is interconnected and exerts synaptic influence in the prefrontal cortex and amygdala, which are also key structures implicated in depression (Degenetais et al., 2003; Ishikawa and Nakamura, 2003; Price and Drevets, 2010) . This integrated circuitry suggests that the hippocampus is functionally related with these structures. Therefore, an impairment in its function caused by stress may cause neurochemical dysfunctions in neuroplasticity pathways in distinct corticolimbic regions (Godsil et al., 2013) .
The acute exposition to a stressful event and the consequent increase in circulating levels of glucocorticoids induce a rapid depolarizationevoked glutamate release in cortical and limbic regions (Lowy et al., Pharmacology, Biochemistry and Behavior 127 (2014) 7-14 Abbreviations: ANOVA, analysis of variance; ARS, acute restraint stress; CAT, catalase; CNS, central nervous system; FST, forced swimming test; GSSG, glutathione disulfide; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, reduced glutathione; H 2 O 2 , hydrogen peroxide; OH•, hydroxyl radical; HO-1, heme-oxygenase-1; MDA, malondialdehyde; NADPH, reduced nicotinamide adenine dinucleotide phosphate; NPSH, non-protein thiols; Nrf-2, nuclear factor (erythroid-derived-2)-like 2; O 2
•− , superoxide anion radical; ROS, reactive oxygen species; SOD, superoxide dismutase; TBARS, thiobarbituric acid reactive substances.
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Pharmacology, Biochemistry and Behavior j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / p h a r m b i o c h e m b e h 1995; Musazzi et al., 2010) . This neurotransmitter displays an important role in neuronal plasticity through the activation of its synaptic receptors (Mattson, 2008) . However, excessive levels of glutamate can cause an overstimulation of extrasynaptic receptors, leading to mitochondrial dysfunction, impairment in the cellular calcium homeostasis and generation of reactive oxygen species (ROS) (Hardingham et al., 2002; Reynolds and Hastings, 1995) . The precursor of most ROS is superoxide anion (O 2 •− ) a product of the reduction of oxygen by one electron. Its dismutation produces hydrogen peroxide (H 2 O 2 ), which in turn may be fully reduced to water or partially reduced to hydroxyl radical (OH•), one of the strongest oxidants in nature (Turrens, 2003) . Although ROS participate in normal cellular processes, they may cause damage to cell components including proteins, nucleic acids, carbohydrates and lipids when associated with an imbalance in antioxidant capacity (Hovatta et al., 2010 (Knapen et al., 1999) . Due to its high rate of oxygen consumption, the central nervous system (CNS) is especially vulnerable to excessive generation of free radicals (Lee et al., 2012) and oxidative damage to neurons has been implicated in the pathogenesis of depression (Zhang and Yao, 2013) . Therefore, the involvement of ROS-mediated pathways and lowered levels of antioxidants in the pathogenesis of depression have been target of several investigations, some of which have pointed to neuroinflammation and altered neurogenesis/neuroplasticity as pivotal phenomena (Maes et al., 2011a) . Depressive patients have significantly elevated plasma levels of peroxide in comparison with normal controls (Maes et al., 2010) as well as higher levels of malondialdehyde (MDA), an indicative of the occurrence of oxidative stress (Ozcan et al., 2004; Sarandol et al., 2007) . As mentioned above, this excessive ROS production can be neutralized by different antioxidant enzymes like superoxide dismutase (SOD), glutathione peroxidase (GPx) or catalase (CAT), which have been reported to be altered in depressive patients (Galecki et al., 2009; Maes et al., 2011b; Ozcan et al., 2004; Sarandol et al., 2007) .
Supporting this hypothesis, there is increasing evidence demonstrating that current antidepressants used in clinical practice may exert their therapeutic effect by regulating oxidative stress (Herken et al., 2007; Khanzode et al., 2003; Kotan et al., 2011) . Taking this into account, it is not surprising that novel antidepressant targets are being considered for investigation based on their antioxidant properties (Lee et al., 2012) , since conventional antidepressants present side effects and may afford incomplete remission (Katalinic et al., 2013; Niciu et al., 2014) .
In this context, guanosine, a guanine-based nucleoside that exhibits protective effects against glutamate excitotoxicity (Frizzo et al., 2002; Vinade et al., 2005) and oxidative stress (Dal-Cim et al., 2012; Petronilho et al., 2012; Tarozzi et al., 2010) , represents an interesting molecule for investigation. In fact, we recently demonstrated that the administration of this nucleoside produces an antidepressant-like effect in the tail suspension test (TST) and in the forced swimming test (FST) similar to the one produced by fluoxetine (Bettio et al., 2012) ; however, the involvement of this effect with hippocampal anti-/pro-oxidative events has not yet been investigated. Considering this background, the present study investigated the protective effect of guanosine against behavioral alterations in the forced swimming test and hippocampal antioxidant imbalance induced by the acute restraint stress (ARS) protocol (Kumar et al., 2010; Moretti et al., 2013; Freitas et al., 2014) .
Materials and methods

Animals
Female Swiss mice (35-45 g), maintained at 20-22°C with free access to water and food and under a 12:12 h light/dark cycle (lights on at 7:00 a.m.) were used. The animals were caged in groups of 15 in a 41 × 34 × 16 cm cage. All behavioral tests were carried out between 9:00 a.m. and 5:00 p.m. Mice were used according to the NIH Guide for the Care and Use of Laboratory Animals and the experiments were performed after approval of the protocol by the Ethics Committee of the Institution. All efforts were made to minimize animal suffering and to reduce the number of animals used in the experiments.
Drugs and treatment
Guanosine and fluoxetine (obtained from Sigma Chemical Co., St. Louis, USA) were dissolved in distilled water and administered orally (p.o.) at a dose of 5 and 10 mg/kg, respectively, 1 h before the ARS procedure. The doses used were chosen based on previous studies (Bettio et al., 2012; Moretti et al., 2013) . Solutions were freshly prepared before administration and administered in a volume of 10 ml/kg. The nonstressed group (control) received distilled water by p.o. route (10 ml/kg). To develop this study, mice were divided into four groups as follows: (1) nonstressed + vehicle; (2) nonstressed + guanosine; (3) stressed + vehicle; and (4) stressed + guanosine. The number of mice per group was 7-9. Fluoxetine was added as a positive control in the forced swimming test (FST) and open field test in another set of experiments.
Acute restraint stress procedure
ARS protocol was performed as previously described (Freitas et al., 2014; Moretti et al., 2013 ) 1 h after the treatment with vehicle, guanosine or fluoxetine. The immobilization was applied for a period of 7 h using an individual rodent restraint device made of Plexiglas fenestrate, restraining all physical movement without causing pain. The animals were deprived of food and water during the entire period of exposure to stress. Non-stressed groups (controls) were treated with vehicle or guanosine and were kept without food and water for 7 h (the same time period of stress). After this time period, independent groups of mice were released from their enclosure and 40 min post-release were submitted to the FST, to the open field test and were sacrificed for the biochemical studies. The control group was submitted to the same protocol, except that it was not submitted to stress.
Behavioral tests 2.4.1. Forced swimming test
Briefly, mice were individually forced to swim in an open cylindrical container (diameter 10 cm, height 25 cm), containing 19 cm of water (depth) at 25 ± 1°C; the total duration of immobility was measured during a 6-min test period by observers blind to the treatment conditions. Each mouse was judged to be immobile when it ceased struggling and remained floating motionless in the water, making only those movements necessary to keep its head above water (Porsolt et al., 1977) .
Open field test
To assess possible interferences on locomotor activity, mice were evaluated in the open field paradigm as previously described. Animals were individually placed in a wooden box (40 × 60 × 50 cm) with the floor divided into 12 equal squares and the number of crossings with all paws was manually counted in a 6-min session. The light was maintained at minimum to avoid anxiety behavior and the apparatus was cleaned with a solution of 10% ethanol between tests in order to hide animal clues Moretti et al., 2013) .
2.5. Biochemical analysis 2.5.1. Tissue preparation 1 h after the ARS procedure, animals were killed by decapitation and the hippocampi were removed and homogenized (1:10 w/v) in HEPES buffer (20 mM, pH 7.0). The tissue homogenates were centrifuged at 16,000 × g, at 4°C for 20 min and the supernatants obtained were used for the determination of enzymatic activities and for the quantification of GSH levels and thiobarbituric acid reactive substances (TBARS). The protein content was quantified by the method of Lowry et al. (1951) using bovine serum albumin as standard. Tissue samples were frozen in liquid nitrogen and stored at −80°C in order to determine the activity of antioxidant enzymes later.
Activity of antioxidant enzymes
Hippocampal glutathione reductase (GR) activity was determined based on the protocol developed by Carlberg and Mannervik (1985) . Briefly, GR reduces glutathione disulfide (GSSG) to GSH at the expense of NADPH. Thus, GR activity was monitored by decreases in NADPH absorbance at 340 nm at 37°C. Results were based on a molar extinction coefficient for NADPH of 6.22 × 10 3 M −1 cm −1
. GPx uses GSH to reduce the tert-butyl hydroperoxide, producing GSSG, which is readily reduced to GSH by GR using NADPH as a reducing equivalent donor. Hippocampal GPx activity was measured through a NADPH reduction assay following the protocol developed by Wendel (1981) . Tissue supernatant (around 200 μg protein) was added to a reaction mixture containing GSH, GR and NADPH in phosphate buffer (pH 7.4). The reaction was initiated by adding tert-butyl hydroperoxide, and the absorbance decrease at 340 nm was recorded at 37°C. The activity in the absence of the samples was subtracted. Results were based on a molar extinction coefficient for NADPH of 6.22 × 10 3 M −1 cm
. Both GR and GPx activities were expressed as nmol NADPH oxidized/min/mg protein.
CAT activity was measured by the method of Aebi (1984) . The reaction was started by the addition of freshly prepared 30 mM H 2 O 2 and the rate of its decomposition by CAT measured spectrophotometrically at 240 nm (enzyme activity expressed as μmol H 2 O 2 consumed/min/ mg protein).
SOD activity was assayed spectrophotometrically as described by Misra and Fridovich (1972) . This method is based on the capacity of SOD to inhibit autoxidation of adrenaline to adrenochrome. The color reaction was measured at 480 nm. One unit of enzyme was defined as the amount of enzyme required to inhibit the rate of epinephrine autoxidation by 50%. The SOD enzymatic activity was expressed as units U/mg protein. The spectrophotometer used for the assays was a TECAN Genios Microplate Reader (Tecan Group Ltd., Männedorf, Switzerland).
Non-protein thiol groups determination
Glutathione (GSH) levels were measured as non-protein thiols (NPSH), based on the protocol developed by Ellman (1959) . This methodology quantifies only the reduced form of glutathione, which is responsible for the antioxidant properties of this peptide. In addition, a small percentage (around 5%) of other low-molecular weight thiols is also measured. Briefly, hippocampal homogenates (fresh tissue) were precipitated in 10% cooled trichloroacetic acid and centrifuged at 5000 ×g for 10 min, and the supernatant was incubated with DTNB (5, 5′-dithio-bis(2-nitrobenzoic acid)) in a 1 M phosphate buffer, pH 7.0. Absorbances were measured at 412 nm. A standard curve of reduced glutathione was used to calculate GSH levels, which were expressed as nmol of NPSH/mg protein.
Thiobarbituric acid reactive species (TBARS) formation
Thiobarbituric acid reactive species (TBARS) formation, a measurement of lipid peroxidation, was determined in the homogenates from fresh tissue according to the method described by Ohkawa et al. (1979) in which MDA, an end-product of lipid peroxidation, reacts with thiobarbituric acid (TBA) to form a colored complex. The samples were incubated at 100°C for 60 min in acid medium containing 0.45% sodium dodecyl sulfate and 0.67% thiobarbituric acid. After centrifugation, the reaction product was determined at 532 nm using MDA as standard.
Statistical analysis
All data are presented as mean ± SEM. Differences among experimental groups were determined by two-way ANOVA followed by Duncan's multiple range post hoc test. Main effects of first order interaction are presented only when interaction was not significant. A value of p b 0.05 was considered to be significant.
Results
Guanosine and fluoxetine prevented the increased immobility time induced by ARS in the FST
The FST is the most widely used behavioral test to measure the antidepressant-like activity of drugs and compounds. Based on its high predictive validity, it was used to evaluate the influence of the treatment with guanosine (5 mg/kg, p.o.) on the immobility time of mice submitted to ARS procedure. The two-way ANOVA revealed a significant main effect for guanosine treatment [F (1, 29) = 14.11, p b 0.01], restraint stress [F (1, 29) = 10.76, p b 0.01] but not for ARS × guanosine treatment interaction [F (1, 29) = 0.018, p = 0.89]. Post hoc analysis indicated that animals treated with guanosine alone exhibited a significant reduction in the immobility time (Fig. 1A, p b 0. 05) compared to control group. Although mice submitted to restraint stress showed an increase in the immobility time (p b 0.05), animals submitted to restraint stress and treated with guanosine presented immobility time similar to that observed in control animals.
In another set of experiments, the selective serotonin reuptake inhibitor fluoxetine (10 mg/kg, p.o.) was administered orally to evaluate the influence of a positive control in the increased immobility time elicited by ARS procedure in the FST (Fig. 1C ). The treatment with this antidepressant prevented the behavioral changes induced by stress [F (1, 27) = 4.51, p b 0.05]. In addition, nonstressed mice treated with fluoxetine did not demonstrate alterations in immobility time as compared to the control group. 
ARS, guanosine and/or fluoxetine did not alter locomotor activity
Guanosine protected mice hippocampus against lipid peroxidation induced by ARS
Due to the short half-life of ROS it is difficult to measure them directly. Therefore, hippocampal TBARS levels were measured, since MDA is a late product of lipid peroxidation. An increased production of MDA is indicative of the occurrence of oxidative damage to membranes, leading to a compromised function and integrity of the cells. In our study, mice submitted to ARS protocol presented a significant increase in hippocampal TBARS, which was abolished by guanosine treatment [F (1,31) = 4.75, p b 0.05]. Post hoc analysis indicated increased levels of TBARS in stressed mice in comparison to nonstressed mice (p b 0.01) and a significant reduction in these levels in stressed mice treated with guanosine (p b 0.05). Treatment of nonstressed group did not produce any significant effect on hippocampal TBARS levels.
Antioxidant profile of mice treated with guanosine and submitted to ARS procedure
GSH is the main nonprotein thiol of the mammalian cell and is involved in the antioxidant response by detoxification of ROS, thus maintaining the redox balance and preventing cell damage. As shown in Fig. 2B , stressed animals did not show any alteration in GSH levels [F (1, 34) = 1.86, p = 0.18] and guanosine treatment did not influence GSH levels in stressed [F (1, 34) = 0.10, p = 0.92] or nonstressed mice [F (1, 34) 
The GSH-dependent detoxification mechanisms involve the enzyme GPx, which reduces peroxides to the corresponding stable alcohols and water. This reaction produces GSSG, which can be converted back to GSH in a reaction catalyzed by GR, at the expense of the reduction of equivalents from NADPH. Regarding GPx activity, the two-way ANOVA revealed a significant main effect of ARS procedure [F (1, 31) = 7.57, p b 0.01] and guanosine treatment [F (1, 31) = 0.79, p = 0.38] but not guanosine × ARS interaction [F (1, 31) = 1.48, p = 0.23] . Post hoc analysis indicated that the exposure to ARS resulted in an enhanced hippocampal activity of GPx (p b 0.05; Fig. 3A ). In addition, the two-way ANOVA of GR activity demonstrated a significant effect of guanosine × ARS interaction [F (1, 31) = 5.90, p b 0.05] (Fig. 3B) . Post hoc analysis found that ARS induced an increased GR activity (p b 0.01) which was prevented by guanosine treatment (p b 0.01).
Superoxide radicals (O 2
•− ) are ROS generated as a by-product of mitochondrial oxidative phosphorylation and from normal cellular biochemical reactions but their excessive amounts can lead to cell damage. The enzyme SOD catalyzes the dismutation of O 2
and is the first line defense against these ROS. In our study, the twoway ANOVA revealed a significant effect to ARS × guanosine interaction [F ( As previously mentioned, H 2 O 2, the product of the reaction catalyzed by SOD, is harmful for most cellular components when accumulated. For this reason, the rapid and efficient removal of H 2 O 2 is of essential importance for all aerobically living cells and CAT plays a significant role for this. The results illustrated in Fig. 4B demonstrate the effect of ARS and guanosine in CAT activity. Two-way ANOVA revealed a significant difference for ARS × guanosine treatment [F (1, 28) 
Post hoc analysis demonstrated that mice submitted to ARS exhibits decreased hippocampal CAT activity in comparison to nonstressed mice (p b 0.01). Guanosine treatment prevented this reduction in hippocampal CAT activity caused by the exposition to ARS (p b 0.01), but did not alter the activity of this enzyme in nonstressed animals.
Some lines of evidence indicate that increased SOD/CAT ratio favors the maintenance of higher levels of H 2 O 2 , since SOD converts O 2
•− to H 2 O 2 , but CAT is not able to metabolize H 2 O 2 to water (Behr et al., 2012; Halliwell, 2007) . In order to evaluate a possible imbalance in H 2 O 2 production, the SOD/CAT ratio was calculated and showed in Fig. 4C . Two-way ANOVA revealed a significant alteration in SOD/CAT ratio in stressed mice [F (1, 28) 
Discussion
A recent study of our group demonstrated that the acute administration of guanosine exerts an antidepressant-like effect in two predictive animal models, the TST and the FST (Bettio et al., 2012) . However, the ability of this nucleoside to counteract behavioral and biochemical alterations induced by an acute stress was not evaluated in female mice, since depression is more prevalent and has a worse clinical outcome in women (Patten et al., 2006) . In this context, the present study sought to investigate the protective effect of this nucleoside against oxidative damage and the coping response to stress evaluated in the FST. The ARS has been proposed as a model that triggers biochemical alterations in mouse brain that can be harmful to CNS function. Among these changes, an increased glutamate release (Satoh and Shimeki, 2010) and an imbalance in oxidant/antioxidant parameters were reported in rodents (Freitas et al., 2014; Kumar et al., 2010) . This resulted increase in ROS production and/or inefficiency in antioxidant systems leads to oxidative stress and is implicated in several psychiatry diseases, including major depression (Bilici et al., 2001; Valko et al., 2007) .
The FST measures the immobility time of animals exposed to an inescapable situation and an increase in this parameter is considered a passive behavior that disengages the animals from active forms of coping with stressful stimulus (Cryan and Mombereau, 2004; Moretti et al., 2013) . In the present study, exposure to ARS caused an increased immobility time in the mouse FST as compared to the control group. Interestingly, the treatment with an oral dose of guanosine (5 mg/kg) resulted in an antidepressant-like effect in nonstressed mice which was not observed in mice administered with fluoxetine (10 mg/kg). This absence of effect observed in mice treated with fluoxetine may be due to the fact that this antidepressant was administered in a single dose 8 h and 40 min before the FST. The extended period of time was not enough to cause a reduction in the immobility time probably because the antiimmobility effect of fluoxetine is related to alterations that occur acutely after its administration. The fact that only guanosine produced an antidepressant-like effect in non-stressed mice reinforces the notion that glutamatergic modulators display antidepressant properties that differ from the monoaminergic agents (Zarate et al., 2010) . Nevertheless, fluoxetine was able to prevent the increased immobility time elicited by ARS, a result similar to previous studies that showed the ability of fluoxetine to abolish the increased immobility time in the mouse FST elicited by restraint stress (Capra et al., 2010; Moretti et al., 2013) . It should be noted that, as none of the groups presented significant differences in the open field test, possible interferences of the ARS procedure or treatments in the locomotor activity can be ruled out.
The analysis of lipid peroxidation confirmed the occurrence of oxidative damage since an increased amount of MDA was found in the hippocampus of mice submitted to ARS. This alteration that follows the submission of rodents to this procedure was also observed in several other studies, reinforcing that this animal model is capable of generating an oxidative stress response (Ahmad et al., 2012; Fontella et al., 2005; Freitas et al., 2014) . In addition, oral administration of guanosine before ARS prevented the enhanced hippocampal lipid peroxidation observed in TBARS assay, suggesting the occurrence of a neuroprotective effect in mice treated with this nucleoside. Taking into account that oxidative alterations are increasingly being recognized as a critical route of damage in the pathophysiology of stress-induced depression (Maes et al., 2011a) , the ability of guanosine to prevent stress-related behavioral changes in FST is likely related to this protective effect against hippocampal oxidative damage. It is noteworthy that this association between major depression and lipid peroxidation can also be found in studies with human subjects (Maes et al., 2011a; Tsuboi et al., 2006) , as well as the reduction in MDA levels when patients are treated with antidepressant drugs (Galecki et al., 2009; Michalakeas et al., 2011) .
Indeed, several antioxidant compounds have been reported to present antidepressant properties (Aboul-Fotouh, 2013; Lobato et al., 2010; Srinivasan et al., 2012) , including GSH (Rosa et al., 2013) . Although alterations in GSH levels in depressive subjects were found (Kodydkova et al., 2009; Rybka et al., 2013) , in our study none of the groups presented any significant alteration in the hippocampal levels of this antioxidant. However, GSH alterations in human depressive subjects are assessed mostly in serum and, although a post-mortem study indicated a decrease in prefrontal cortex (Gawryluk et al., 2011) , it still not clear if hippocampal levels are also altered in human patients. Furthermore, in line with our findings, other studies also found that ARS procedure causes an imbalance in various oxidative/antioxidant parameters without causing changes in GSH levels Mendez-Cuesta et al., 2011; Moretti et al., 2013) , which might be related to the cell's ability to restore GSH levels after pro-oxidative challenges. The GSHrelated antioxidant system was also investigated through the measurement of GPx and GR activities. Regarding these parameters, increased GPx and GR activities were found in the hippocampus of mice submitted to ARS procedure, a response that is likely due to an increase in ROS generation following the stressor. Furthermore, the administration of guanosine prevented this alteration, suggesting that this nucleoside may attenuate the oxidative damage induced by ARS.
One of the main factors implicated in stress-induced oxidative damage is the overproduction of O 2
•− , which can lead to neuronal atrophy in the brain (Seo et al., 2012) . Therefore, our study evaluated SOD activity and found that hippocampal activity of this enzyme was increased in mice submitted to ARS. It is noteworthy that ROS generation triggers a response that activates the nuclear factor (erythroid-derived-2)-like 2 (Nrf-2), a primary transcriptional regulator of a majority of antioxidants, including SOD and heme oxygenase-1 (HO-1) (Deramaudt et al., 2013 ). This may be a possible explanation to the increased SOD activity that we observed after stress exposure. Besides, although the nonstressed group treated with guanosine did not show any alteration in SOD activity, this nucleoside caused a higher increase in the activity of this enzyme as compared with stressed mice treated with vehicle. In fact, it is reported that the neuroprotective effect of guanosine is mediated by HO-1 (Dal-Cim et al., 2012) . Considering that an overexpression of SOD in several tissues is associated with increased HO-1 levels (Fan et al., 2012; Khalaj et al., 2013; Turkseven et al., 2005) , further studies are necessary to establish the direct relationship between the antidepressant-like effect of guanosine and the antioxidant response.
The increased SOD activity in stressed mice may generate significant amounts of H 2 O 2 , which, in turn, could stimulate enzymes that convert this peroxide into water and molecular oxygen. Indeed, this can be one explanation for the increased GPx activity found in stressed mice treated with vehicle although our data also demonstrated that the ARS procedure leads to a reduction in CAT activity in this group. However, this result is in line with other studies that found a reduction in CAT activity in the hippocampus following ARS procedure (Freitas et al., 2014; Khalaj et al., 2013; Kumar et al., 2010) . H 2 O 2 can be metabolized into OH• and its excessive generation may be involved in the initiation of the lipid peroxidation observed in the present study, since an enhanced SOD activity was associated with a decline in CAT. Furthermore, the analysis of SOD/CAT ratio did not show a significant imbalance in ARSsubjected mice treated with guanosine. This observation may be due to the fact that, although this nucleoside triggers a response that raised SOD activity in ARS-subjected mice, excessive H 2 O 2 may be at least partially neutralized by CAT, whose activity was not changed (in opposition to animals subjected to ARS alone).
Despite the fact that major depression is one of the most common psychiatry disorders and is associated with high rates of disability, the therapeutic alternatives present a variety of side effects and a lag period of several weeks in the onset of action (Covington et al., 2010; Zarate et al., 2006) . In this context, it has been demonstrated that antioxidant compounds as well as glutamate modulators are promising targets for new therapeutic alternatives in the treatment of this disorder (Niciu et al., 2014; Scapagnini et al., 2012) . Since excitotoxicity and oxidative stress are reported to act synergistically to induce neuronal damage (Trotti et al., 1998) , guanosine may be proposed as a putative antidepressant agent. Interestingly enough, this compound may be promising for the management of depression considering its low toxicity (Schmidt et al., 2010) .
Conclusions
Altogether, our data demonstrated that the oral administration of guanosine prevented behavioral alterations in the FST as well as hippocampal oxidative imbalance in animals subjected to the ARS protocol. The present study reinforces the notion that this nucleoside may be an endogenous mood modulator endowed with neuroprotective properties.
